Earlier Anti-Tumor Necrosis Factor Therapy of Crohn’s Disease Correlates with Slower Progression of Bowel Damage
David B. Sachar(Mount Sinai Hospital), Judy H. Cho(Cedars-Sinai Medical Center), Mathilde Wagner(Sorbonne Université), Marla C. Dubinsky(Icahn School of Medicine at Mount Sinai), Jeromy Patterson(Emory University), Ryan C. Ungaro(Feinstein Institute for Medical Research), Russell B. McBride(Icahn School of Medicine at Mount Sinai), Bachir Taouli(Cornell University), Manjil Chatterji(Icahn School of Medicine at Mount Sinai)
Cited by 23
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Inflammatory Bowel Disease
|New England Journal of Medicine|2009|2.7k